Congenital malformations present at delivery of an infant are due to genetic or non genetic factors and occur in 15-20% of stillborn children. Most can be diagnosed prenatally by ultrasound examination, but some can only be diagnosed after birth. Seven to 10% of infants with abnormal phenotype have numerical or structural chromosomal abnormalities that require identification for accurate diagnosis and genetic counseling. Molecular-cytogenetic and array-based techniques have enabled screening at higher resolution for congenital anomalies that result from genomic imbalances. We have examined four children with congenital anomalies, with or without mental retardation, of unclear etiology. In one child, we detected a deletion (about 28 Mb) of the region 18q21.1-18q23, in mosaic form. This abnormality was missed in a routine cyto genetic examination. We detected different polymorphic copy number variations (CNVs) in the other children. We conclude that array-based comparative genomic hybridization (CGH) is a powerful diagnostic tool for the detection of low level mosaicism.
INTRODUCTION
In Bulgaria, about 2,100 children are born with congenital malformations annually. Most malformations are present at delivery and are due to genetic and non genetic factors [1] . They occur at a relatively constant population frequency of 2-4% independent of race, culture and social-economic environment, and are observed in 15-20% of stillborn infants. About 60% of infants with malformations are diagnosed during the first month of life and about 80% by the end of the third month. With the introduction of ultrasonography in the routine clinical examination of pregnancy, severe congenital anomalies can be diagnosed antenatally [2] , but many congenital defects cannot be diagnosed during pregnancy. About 20-25% of congenital malformations are considered to be multifactorial, and 10-13% are due to environmental factors such as infection, drugs or maternal disease [3, 4] . The rest have no known cause. Chromosome abnormalities have long been recognized as an important cause of multiple malformation syndromes, 7-10% of infants with abnormal phenotype having numerical or structural chromosomal aberrations [5] . Their identification is important for accurate diagnosis and genetic counseling.
The most frequent structural chromosomal abnormalities include unbalanced translocation, duplication, deletion, isochromosomes, ring chromosomes and micro-structural aberrations [5] . Some are so minor that they cannot be diagnosed by classical karyotyping. These include micro deletions or microduplications, some of them being associated with recognizable syndromes. The affected regions on the chromosome include genes which may contribute separately or simultaneously to the characteristics of the phenotype [6] . We have studied four patients with normal karyotypes who suffered from congenital malformations with or without mental retardation, by means of array-based comparative genomic hybridization (CGH) to detect microstructural genomic abnormalities and/or polymorphic regions.
CASE HISTORIES
Patient 1 was a male aged 3 years and 4 months with a normal mental development. He had a developed asymmetry of the lower limbs, left-sided microdactyly and hyperthelorism. He had undergone two operations for resection of tumors in the right kidney and the liver. The routine cytogenetic analysis did not reveal any chromosomal abnormalities and showed a normal male karyotype (46,XY).
Patient 2 was a female aged 9 years and 4 months with a severe mental retardation, speech deficiency and low intelligence (IQ 25). She had facial dysmorphism, congenital dysplasia of the pelvic joint, contractures of the ankle joints and epilepsy. There was no evidence of metabolic disorder. Cytogenetic analysis showed a normal female karyotype (46,XX). The diagnosis was "mental retardation of unclear etiology." Patient 3 was a male aged 2 years and 7 months with severe mental retardation, lack of speaking ability, hypo tonic muscles, microcephaly and facial dysmorphism. There were no anomalies of the heart, kidneys and gastro-intestinal tract. The karyotype was normal (46,XY). The diagnosis was "malformative syndrome of unclear etiology."
Patient 4 was a female aged 13 years and 8 months with a severe mental retardation (IQ 5), epilepsy, spastic paresis of limbs and hyperactivity. There was facial dys morphism -hypertelorism and convergent strabismus, but no organ anomalies. The karyotype was normal (46,XX). The diagnosis was "malformative syndrome of unclear etiology."
MATERIALS AND METHODS
The study was approved by the Ethics Committee of the Medical University of Sofia, Sofia, Bulgaria. The parents of the children provided their informed consent. Peripheral blood was taken for genetic diagnostic testing.
Chromosome Analysis. G-banded chromosomes were prepared from whole blood samples using standard laboratory protocol.
DNA Extraction. DNA was extracted from blood samples by phenol-chloroform. The yield and purity for protein/RNA were estimated by a Nanodrop 1000 spectro photometer (Thermo Scientific, Wilmington, DE, USA). The DNA was checked on a 1% agarose gel: DNA of high molecular weight (>50 kb) indicated it was suitable for use.
Genomic Arrays. We have used genomic array Cyto Chip (BlueGnome, Cambridge, Cambridgeshire, UK), cov ering the entire genome by bacterial artificial chromosome (BAC) clones at a median 565 kb, a resolution optimized to detect pathogenic imbalances while minimizing polymorphisms. In addition, sub-telomeric clones were included at a median 250 kb resolution, thus allowing reliable detection of mosaicism. The BAC clones of 90 known genetic conditions at a median 100 kb resolution were also included in the chip. This resulted in an average density of 1 clone/0.5 Mb.
Probe Labeling, Hybridization, Image Capture and Data Analysis. Test-and sex-matched reference genomic DNA (400 ng) was labeled by random-priming, using a fluorescent labeling system (BlueGnome). The labeled products were purified by AutoSeq™ G50 columns (Amersham Pharmacia Biotech Inc., Piscataway, NY, USA), and the incorporation of dyes was evaluated by the spectrophotometer (Nanodrop 1000, Thermo Scientific). Incorporation in the range of 6-15 pmol/µL and a DNA yield of 180-325 ng/µL were considered suitable for further analysis. A mix of Cy5-and Cy3-labeled probes and a mix of COT-1 and Herring sperm DNA were ethanol-precipitated at -80°C for at least 30 min. Hybridization was done using dissolved precipitated probes in a hybridization buffer.
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Arrays were washed in sodium chloride-sodium citrate (SSC) buffers with decreasing concentrations and scanned by a GenPix 4100A (Axon Instruments, Union City, CA, USA). The images were analyzed by BlueFuse for Microarrays 3.5 software (BlueGnome). In data processing log 2 ratios of Cy3 and Cy5, intensities were generated for all hybridized clones. Normal copy numbers were considered to be present if the log 2 ratio was between -0.3 and +0.3, values above +0.3 were interpreted as gain/ amplification and those under -0.3 as losses (deletions). Genomic profiles were represented plotting log 2 ratios in Y-axis and the 23 chromosomes in Xaxis. Individual chromosomal profiles were represented with clone positions in Y-axis and log 2 ratios in X-axis.
RESULTS
We studied blood from our four patients by the method of array-CGH with CytoChip (BlueGnome), covering all autosomes and sex chromosomes at a mean density of 1 BAC clone/0.5 Mb. More than 95% of genomic clones were successfully hybridized in each case. Standard deviation in log 2 ratios of Cy3 and Cy5 intensities [test (T) and normal (N) DNA, respectively] ranged between 0.03 and 0,07, depending on the quality of DNA.
We used two approaches to identify BACs that showed significant loss or gain in the analyzed samples: a) observation of high-level loss (log 2 T:N ratio <-0.5) and of high-level gain (log 2 T:N ratio >+0.5) and b) detection of at least one additional adjacent clone with the same aberration in the same probe. The single aberrant clones were excluded from analysis. Using the data base of Blue Fuse (BlueGnome) we determined the copy number poly morphisms in the patients.
In patient 1, we found no specific micro-abnormality, but discovered a polymorphism in the following loci: 2p25. 3 Figure 1 ). Their population frequency varied between 1-60% according to the BlueGnome data base.
In patient 2, no specific abnormalities were found but seven loci showed a variable number of gene copies (polymorphic regions) in the follow- In patient 3, array-CGH analysis revealed genomic loss in the long arm of chromosome 18, which, on the basis of the value of log 2 ratio, was interpreted as a mosaic form (Figure 2) . The deletion comprised a DNA sequence from 18q21.1 to 18q23 (about 28 Mb) (Figure 3) . Beside the deletion, we identified gene copy polymorphisms in positions 8p23.1, 10q26.3 and Yp11.2 On the basis of the presence of the large deletion 18q21-23, we repeated cyto genetic analyses in 100 cells and found a low frequency of mosaicism: 46, XY (83%)/46,XY,del (18)(q21-qter) (Figure 4) . 
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In patient 4, we established copy number polymor phisms in the loci 1p31.1, 4p16.1 and 8p23.2.
DISCUSSION
We used the technique of array-CGH to screen micro-structural whole genome copy number changes in four patients with congenital malformations. We detected a specific genomic abnormalities in one of the four patients and different copy number polymorphisms in all four patients. This technique permits identification at a high resolution of micro-structural abnormalities in human chromosomes [7] . In comparison to fluorescent in situ hybridization (FISH) and classical cytogenetic diagnostics, the method has a much higher sensitivity and permits screening of the whole genome simultaneously for unbalanced micro-structural rearrangements [8] . It is also applicable for effective screening of new dose-dependent genes, which are important for the emergence of many human diseases [9] . The use of the BAC clones ensures strong and large signals that can be measured over a broad range -from deletions to amplifications [9, 10] .
We established copy number polymorphisms in all of our patients. According to recent publications [11-13], more than half of the variability between human genomes is due to copy number variations (CNVs) of small regions of DNA. It is hypothesized that these CNVs are responsible for some complex diseases and are more frequent than single nucleotide polymorphisms [11] [12] [13] . There are more than 6,000 known regions of CNV, and there may be many more [13, 14] . The impact of CNVs in the development of congenital malformations remains to be seen.
Our most interesting finding was the loss of genetic material from chromosome 18 in patient 3. This deletion comprises the region 18q21.1-q23 and encompassed 48 deleted BAC clones. The 18q syndrome (OMIM #601808) is characterized by mental retardation, facial dysmor phism, congenital malformations and deformities of the feet, depending on the size of the deleted region [15] . The critical region in the 'typical' 18q phenotype is one of 4.3 Mb located within 18q22.3-q23. A recent study investigated partial deletions of the long arm of chromosome 18 and identified critical regions for microcephaly (18q21.33), short stature (18q21.--q21.33, and 18q22.3-q23), white matter disorders (18q22.3-q23) and CAA (congenital aural atresia) (18q22.3) [15] . These observations are consistent with the clinical symptoms in our patient. During investigation of the deleted region in the long arm of chromosome 18 by genome browser, we delineated 149 genes, of which some have no known function.
Other genes in this region may also be related to the abnormal phenotype. Among these we found genes with regulatory function (ZNF236, zinc finger protein 236), transcription coactivators and regulators [DCC, deleted in colorectal carcinoma; RAX, retina and anterior neural fold homeo box; TSHZ1, teashirt family zinc finger 1), translation regulators A B
(NARS, asparaginyl-tRNA synthetase), transporters (CCBE1, collagen and calciumbinding EGF domains 1), inducte of apoptosis (PMAIP1, phorbol-12-myristate-13-acetate-induced protein 1), regulators of cell growth (SOCS6, suppressor of cytokine signaling 6; PARD6G, par-6 partitioning defective 6 homolog gamma (C. elegans)] and others. These genes may be good candidates for further functional studies, as candidate genes for the human development and congenital anomalies. Our concurrent array CGH analysis and karyotyping in the patient with 18q deletion, showed that microarray technology is useful for the detection of low level mosaicism.
CONCLUSIONS
We have used the method of array-CGH on DNA from four patients with "mental retardation of unclear etiology" and have analyzed whole genome copy number at a high resolution. We detected different copy number polymor phisms in all patients. We have identified a mosaic form of deletion 18q21.1-q23 in one of the patients.
The use of array-CGH technology increases our understanding of the normal quantitative variants of the human genome and makes possible determination of the exact size and the boundaries of the deletion in patients. We could thus obtain the precise information necessary for adequate genetic counseling of the families affected by various aneuploidies.
